Login to Your Account

Clinic Roundup

Monday, October 29, 2012
• Galena Biopharma Inc., of Lake Oswego, Ore., said data from a Phase I/II study showed that NeuVax (nelipepimut-S or E75) decreased circulating tumor cells in 16 of 26 breast cancer patients during vaccine treatment.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription